The expression of the ΔNp73β isoform of p73 leads to tetraploidy

European Journal of Cancer

Volumn 45, Issue 3, 2009, Pages 443-453

  Marrazzo, E ^a   Marchini, S ^a   Tavecchio, M ^a   Alberio, T ^a   Previdi, S ^a   Erba, E ^a   Rotter, V ^b   Broggini, M ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Np73; Cell cycle; Mitosis; TAp73; Tetraploidy

Indexed keywords

BROXURIDINE; PROTEIN P73; DNA BINDING PROTEIN; ISOPROTEIN; NUCLEAR PROTEIN; TP73 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CLONOGENIC ASSAY; GENE LOCUS; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE MICROSCOPY; LUNG CARCINOMA; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TETRAPLOIDY; TUMOR CELL; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETICS; LUNG SMALL CELL CANCER; METABOLISM; PHYSIOLOGY; POLYPLOIDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL CYCLE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MITOSIS; NUCLEAR PROTEINS; POLYPLOIDY; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA; TUMOR SUPPRESSOR PROTEINS;

EID: 59149092149     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.09.024     Document Type: Article

References (33)

1. Sigal A., and Rotter V. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res 60 24 (2000) 6788-6793
2. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 6810 (2000) 307-310
3. Strano S., Rossi M., Fontemaggi G., et al. From p63 to p53 across p73. FEBS Lett 490 3 (2001) 163-170
4. Moll U.M., Erster S., and Zaika A. P53, p63 and p73 - solos, alliances and feuds among family members. Biochim Biophys Acta 1552 2 (2001) 47-59
5. Moll U.M., and Slade N. P63 and p73: roles in development and tumor formation. Mol Cancer Res 2 7 (2004) 371-386
6. Liu G., Nozell S., Xiao H., and Chen X. DeltaNp73beta is active in transactivation and growth suppression. Mol Cell Biol 24 2 (2004) 487-501
7. Nozell S., Wu Y., McNaughton K., et al. Characterization of p73 functional domains necessary for transactivation and growth suppression. Oncogene 22 28 (2003) 4333-4347
8. Chen X. The p53 family: same response, different signals?. Mol Med Today 5 9 (1999) 387-392
9. Harms K., Nozell S., and Chen X. The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci 61 7-8 (2004) 822-842
10. Fontemaggi G., Kela I., Amariglio N., et al. Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses. J Biol Chem 277 45 (2002) 43359-43368
11. Fulco M., Costanzo A., Merlo P., et al. P73 is regulated by phosphorylation at the G2/M transition. J Biol Chem 278 49 (2003) 49196-49202
12. Merlo P., Fulco M., Costanzo A., et al. A role of p73 in mitotic exit. J Biol Chem 280 34 (2005) 30354-30360
13. Kartasheva N.N., Contente A., Lenz-Stoppler C., Roth J., and Dobbelstein M. P53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Oncogene 21 31 (2002) 4715-4727
14. Grob T.J., Novak U., Maisse C., et al. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 8 12 (2001) 1213-1223
15. Petrenko O., Zaika A., and Moll U.M. ΔNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo. Mol Cell Biol 23 16 (2003) 5540-5555
16. Stiewe T., Zimmermann S., Frilling A., Esche H., and Putzer B.M. Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res 62 13 (2002) 3598-3602
17. Kartasheva N.N., Lenz-Bauer C., Hartmann O., Schafer H., Eilers M., and Dobbelstein M. DeltaNp73 can modulate the expression of various genes in a p53-independent fashion. Oncogene 22 51 (2003) 8246-8254
18. Tanaka Y., Ota K., Kameoka M., Itaya A., and Yoshihara K. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells. Exp Cell Res 312 8 (2006) 1254-1264
19. Marabese M., Marchini S., Sabatino M.A., Polato F., Vikhanskaya F., Marrazzo E., et al. Effects of inducible overexpression of DNp73[alpha] on cancer cell growth and response to treatment in vitro and in vivo. Cell Death Differ 12 7 (2005) 805-814
20. Marrazzo E., Marchini S., Previdi S., and Broggini M. Questioning the oncogenic role of DeltaNp73alpha in different cell lines expressing p53 or not. Cancer Biol Ther 5 7 (2006) 794-803
21. Sabatino M.A., Previdi S., and Broggini M. In vivo evaluation of the role of DNp73alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs. Int J Cancer 120 3 (2007) 506-513
22. Irwin M.S. DeltaNp73: misunderstood protein?. Cancer Biol Ther 5 7 (2006) 804-807
23. Norbury C., and Nurse P. Animal cell cycles and their control. Ann Rev Biochem 61 (1992) 441-470
24. Pozniak C.D., Radinovic S., Yang A., McKeon F., Kaplan D.R., and Miller F.D. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289 5477 (2000) 304-306
25. Muller M., Schilling T., Sayan A.E., Kairat A., Lorenz K., Schulze-Bergkamen H., et al. TAp73/DeltaNp73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ 12 (2005) 1564-1577
26. Roninson I.B., Broude E.V., and Chang B.D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 4 5 (2001) 303-313
27. Shammas M.A., Koley H., Batchu R.B., et al. Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 4 (2005) 24
28. Herbert B.S., Pongracz K., Shay J.W., and Gryaznov S.M. Oligonucleotide N3' → P5' phosphoramidates as efficient telomerase inhibitors. Oncogene 21 4 (2002) 638-642
29. Racek T., Mise N., Li Z., Stoll A., and Putzer B.M. C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter. J Biol Chem 280 49 (2005) 40402-40405
30. Beitzinger M., Oswald C., Beinoraviciute-Kellner R., and Stiewe T. Regulation of telomerase activity by the p53 family member p73. Oncogene 25 6 (2006) 813-826
31. Mansilla S., Priebe W., and Portugal J. Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. Cell Cycle 5 1 (2006) 53-60
32. Andreassen P.R., Martineau S.N., and Margolis R.L. Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. Mutat Res 372 2 (1996) 181-194
33. Kops G.J., Weaver B.A., and Cleveland D.W. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5 10 (2005) 773-785